Atomistry » Sodium » PDB 2x5x-2xjq » 2xbw
Atomistry »
  Sodium »
    PDB 2x5x-2xjq »
      2xbw »

Sodium in PDB 2xbw: Factor Xa in Complex with A Pyrrolidine-3,4-Dicarboxylic Acid Inhibitor

Enzymatic activity of Factor Xa in Complex with A Pyrrolidine-3,4-Dicarboxylic Acid Inhibitor

All present enzymatic activity of Factor Xa in Complex with A Pyrrolidine-3,4-Dicarboxylic Acid Inhibitor:
3.4.21.6;

Protein crystallography data

The structure of Factor Xa in Complex with A Pyrrolidine-3,4-Dicarboxylic Acid Inhibitor, PDB code: 2xbw was solved by D.W.Banner, J.Benz, D.Schlatter, S.Thomi, W.Haap, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 19.45 / 1.72
Space group P 43 21 2
Cell size a, b, c (Å), α, β, γ (°) 105.680, 105.680, 49.650, 90.00, 90.00, 90.00
R / Rfree (%) 19.2 / 21.8

Other elements in 2xbw:

The structure of Factor Xa in Complex with A Pyrrolidine-3,4-Dicarboxylic Acid Inhibitor also contains other interesting chemical elements:

Fluorine (F) 1 atom
Calcium (Ca) 1 atom
Chlorine (Cl) 1 atom

Sodium Binding Sites:

The binding sites of Sodium atom in the Factor Xa in Complex with A Pyrrolidine-3,4-Dicarboxylic Acid Inhibitor (pdb code 2xbw). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Factor Xa in Complex with A Pyrrolidine-3,4-Dicarboxylic Acid Inhibitor, PDB code: 2xbw:

Sodium binding site 1 out of 1 in 2xbw

Go back to Sodium Binding Sites List in 2xbw
Sodium binding site 1 out of 1 in the Factor Xa in Complex with A Pyrrolidine-3,4-Dicarboxylic Acid Inhibitor


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Factor Xa in Complex with A Pyrrolidine-3,4-Dicarboxylic Acid Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Na1247

b:29.8
occ:1.00
 O A:LYS224 2.3 22.8 1.0
O A:TYR185 2.4 25.3 1.0
O A:ARG222 2.4 26.9 1.0
O A:HOH2180 2.5 33.3 1.0
O A:HOH2205 2.6 28.9 1.0
O A:ASP185A 2.7 32.0 1.0
C A:ASP185A 3.4 31.1 1.0
C A:LYS224 3.4 21.4 1.0
C A:ARG222 3.5 28.4 1.0
C A:TYR185 3.5 26.2 1.0
N A:LYS224 3.6 22.5 1.0
CA A:ASP185A 3.9 30.4 1.0
C A:ALA221 4.1 27.6 1.0
CA A:LYS224 4.1 22.2 1.0
N A:GLY223A 4.1 25.5 1.0
N A:ARG222 4.1 27.8 1.0
N A:ASP185A 4.2 28.8 1.0
O A:ALA221 4.2 30.1 1.0
CA A:LYS223 4.3 27.8 1.0
N A:LYS223 4.3 26.7 1.0
N A:THR185B 4.3 31.7 1.0
O A:HOH2182 4.4 28.6 1.0
CA A:ARG222 4.4 27.9 1.0
C A:LYS223 4.4 25.7 1.0
CA A:ALA221 4.5 27.4 1.0
N A:TYR225 4.5 18.6 1.0
CB A:LYS224 4.6 22.5 1.0
C A:GLY223A 4.7 25.9 1.0
CA A:TYR185 4.7 26.5 1.0
CA A:THR185B 4.7 32.8 1.0
CA A:TYR225 4.8 19.4 1.0
O A:LYS186 4.8 33.2 1.0
CA A:GLY223A 4.9 26.1 1.0
N A:TYR185 4.9 24.6 1.0

Reference:

L.Anselm, D.W.Banner, J.Benz, K.Groebke Zbinden, J.Himber, H.Hilpert, W.Huber, B.Kuhn, J.L.Mary, M.B.Otteneder, N.Panday, F.Ricklin, M.Stahl, S.Thomi, W.Haap. Discovery of A Factor Xa Inhibitor (3R,4R)-1-(2,2-Difluoro-Ethyl)-Pyrrolidine-3,4-Dicarboxylic Acid 3-[(5-Chloro-Pyridin-2-Yl)-Amide] 4-{[2-Fluoro-4-(2-Oxo-2H-Pyridin-1-Yl)-Phenyl]-Amide} As A Clinical Candidate. Bioorg.Med.Chem. V. 20 5313 2010.
ISSN: ISSN 0968-0896
PubMed: 20650636
DOI: 10.1016/J.BMCL.2010.06.126
Page generated: Mon Oct 7 05:08:24 2024

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy